August 27, 2019

Maximizing patient retention with investigator feedback

Following a successful patient recruitment period, a clinical operations team within a leading pharmaceutical company wanted to reduce the risk of patients deciding to prematurely discontinue participating in a clinical study.
maximizing patient retention

GOALS

Following a very successful patient recruitment period, a pharmaceutical company’s clinical operations team wanted to reduce the risk of patients deciding to prematurely discontinue a clinical study. To increase the likelihood of maximizing patient retention, the team set the following goals:

  1. Gathering feedback from study investigators on best practices, patient assistance services, and study support materials
  2. Gaining insight into patient and caregiver experiences
  3. Identifying gaps or opportunities for additional patient support

SOLUTION

The clinical operations team used the Within3 insights management platform to gain insights from investigators across multiple study sites. Questions included “What do you think could be the main reason for patients to discontinue this study prematurely?” and “What material provided for the study do patients find useful?” Investigators were able to complete the survey whenever it was convenient for them, on any device, including tablets and smartphones. Moderators used the platform’s capabilities to probe for more information or provide additional context when needed. The moderators also could ask private questions, which allowed investigators to be completely candid in their responses or to have short one-on-one discussions with moderators.

RESULTS

The clinical operations team received responses from investigators around the world. Investigators provided detailed information about patient experiences with clinical site visits, assessment materials, support materials, and other aspects of the study. The clinical operations team obtained valuable information to improve patient retention, including:

  1. Suggestions for clinical site visits to improve the experience for investigators, patients, and caregivers
  2. Insights on additional patient support materials to increase the likelihood of continued participation
  3. Feedback on operational aspects of the study to apply these learnings to future studies

Ready to learn more? Get our guide to virtual investigator meetings.

Client Results

Two dozen countries, one mission: rare disease task force

FYMCA Medical Ltd, a UK-based company that develops improved rare disease education and services for the developing world, wanted to identify problems impacting the care
market access strategy pharma

Improving market access strategy in pharma

Steering committees play a key role in addressing questions ranging from clinical insights and market penetration and expansion to issues around access and coverage.

Unlock the transformative power of insights

Discover how insights management can transform your business operations and accelerate key milestone achievements.

Book a demo session